Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01456468
Recruitment Status : Completed
First Posted : October 20, 2011
Last Update Posted : July 14, 2016
Mayo Clinic
Information provided by (Responsible Party):
James Boyer, Yale University